Friday 6 November 2026
Export HRMY’s income statement to Excel — free account
Harmony Biosciences Holdings, Inc.
HRMY Healthcare Biotechnology
Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024.
- Revenue
- +12.3%
- EPS
- −6.24%
- Free cash flow
- −29.4%
- Total debt
- −11.5%
Quarter to September 2026, against a year earlier
33.04
0.57
+1.76%
Follow HRMY
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 4 | 5 |
+8 more TTM periods Free account |
| 18.73% | 20.46% | 17.86% | 20.75% | ||
| 13.30% | 14.61% | 12.51% | 13.98% | ||
ROIC |
30.45% | 29.70% | 27.66% | 50.40% | |
Return on Tangible Assets |
26.93% | 31.24% | 25.93% | 24.23% | |
Average Days of Receivables |
47.13 | 42.21 | 43.93 | 40.68 | |
Free Cash Flow per Share |
5.53 | 6.13 | 5.91 | 6.05 | |
Free Cash Flow |
323.04 | 355.08 | 341.97 | 347.89 | |
Capital Expenditures |
— | — | — | (0.31) | |
| Other line items | |||||
Cash ROIC |
16.21% | 19.50% | 20.00% | 19.23% | |
Accounts Receivable Turnover |
8.66 | 9.41 | 8.40 | 9.66 | |
Accounts Payable Turnover |
9.65 | 9.44 | 9.16 | 12.62 | |
Inventory Turnover |
40.30 | 37.87 | 36.15 | 31.60 | |
Average Days of Payables |
38.24 | 33.55 | 49.51 | 32.56 | |
Days of Inventory on Hand |
8.34 | 9.84 | 9.14 | 9.86 | |
Tax Rate |
(0.23) | (0.25) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
24.01% | 23.01% | 24.96% | 21.83% | |
Selling, General and Administrative Expense of Revenue |
27.84% | 28.39% | 30.51% | 31.33% | |
Share Based Compensation of Revenue |
3.84% | 4.26% | 4.78% | 5.17% | |
Interest Coverage |
16.99 | 17.12 | 13.49 | 14.23 | |
Operating CF/Net income |
1.81 | 1.96 | 2.35 | 2.19 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.01) | |
Revenue per Share |
16.94 | 16.57 | 15.55 | 15.11 | |
Operating CF per Share |
5.53 | 6.13 | 5.91 | 6.06 | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026